The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Bisphosphonate treatment of primary breast cancer patients with disseminated tumor cells in the bone marrow.
Andreas D. Hartkopf
No relevant relationships to disclose
Markus Wallwiener
No relevant relationships to disclose
Markus Hahn
No relevant relationships to disclose
Diana Stefanescu
No relevant relationships to disclose
Sven Becker
No relevant relationships to disclose
Erich Solomayer
No relevant relationships to disclose
Tanja Fehm
No relevant relationships to disclose
Sara Brucker
No relevant relationships to disclose
Diethelm Wallwiener
No relevant relationships to disclose
Florin-Andrei Taran
No relevant relationships to disclose